Dermata Therapeutics, Inc.
DRMA
$6.45
$0.2183.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 5.05% | 22.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.89% | -0.79% | |||
| Operating Income | 26.89% | 0.79% | |||
| Income Before Tax | 26.89% | 0.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.89% | 0.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.89% | 0.70% | |||
| EBIT | 26.89% | 0.79% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 51.26% | 55.08% | |||
| Normalized Basic EPS | 51.27% | 55.07% | |||
| EPS Diluted | 51.26% | 55.08% | |||
| Normalized Diluted EPS | 51.27% | 55.07% | |||
| Average Basic Shares Outstanding | 49.99% | 121.05% | |||
| Average Diluted Shares Outstanding | 49.99% | 121.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||